IPOPI, the International Patient Organisation for Primary Immunodeficiencies, is delighted to launch PID GENIUS, the first mobile application developed by a patient organisation for people with primary immunodeficiencies (PIDs) for worldwide use. This project has been made possible thanks to the support of Kedrion Biopharma and is now available for download at the Apple App Store and on Google Play.
PID GENIUS is the personal assistant to PID patients in search of an easy and dynamic way of keeping track of their treatments, day-to-day symptoms, vaccinations, contacts, most important documents. PID GENIUS also offers the possibility of displaying stored information in dashboards, facilitating discussions between patients and their medical specialists. “We hope that with this mobile application, people living with PIDs will see the management of their day-to-day life and treatment become simpler and easier to follow up, sparing them the trouble of managing with a big bulk of files”, said Jose Drabwell, from IPOPI.
IPOPI has developed PID GENIUS to help people living with primary immunodeficiencies organise all the information they need and make it available at any time, including in case of emergency.
Kedrion Biopharma is an IPOPI longstanding partner in its goal of advancing disease awareness and access to care for all PID patients worldwide. PID Genius is the latest initiative developed together. “For us, innovation means contributing, every day, to improve the quality of life of people living with Primary Immunodeficiencies and other rare diseases”, Ferdinando Borgese, Regional Commercial Director Asia, Middle East & Africa at Kedrion Biopharma stated.